BREAKING UPDATE: Today, the U.S. Supreme Court granted a stay of an order issued by the Fifth Circuit Court of Appeals in Louisiana v. FDA. The FDA’s current rules, which allow people to receive mifepristone by mail or pharmacy, are now in place as the case proceeds on the merits.
